Search research articles
Contact Us
Filters
Showing results (1-10 of 277) with videos related to
Page
of 28
Sort By:
Rheumatology (Oxford, England)
|
December 14, 2007
COBRA combination therapy in daily practice--getting back to the future
M Boers
The Journal of Rheumatology
|
September 16, 2000
MRI for the early detection of sacroiliitis
M Boers
Nederlands Tijdschrift Voor Geneeskunde
|
October 26, 2000
[Roaming through methodology. XXV. Outcome measures, surrogate outcomes, and intermediate measures]
M Boers
The American Journal of Medicine
|
March 1, 1989
The prospects of autopsy: mortui vivos docuerunt? ("Have the dead taught the living?")
M Boers
Arthritis and Rheumatism
|
November 17, 2001
Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy
M Boers,
The Netherlands Journal of Medicine
|
December 17, 2002
EMEA guidelines for trials in osteoporosis: design implications
M Boers
Rheumatic Diseases Clinics of North America
|
June 9, 2001
Rheumatoid arthritis. Treatment of early disease
M Boers
The Journal of Rheumatology
|
October 1, 1994
Predicting outcome of ankylosing spondylitis: prognosis or hindsight?
M Boers
Lancet (London, England)
|
June 22, 2001
NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection
M Boers
The Journal of Rheumatology
|
August 18, 2001
Bias in its coat of many colors
M Boers
Page
of 28
Search research articles
Search
Showing results (1-10 of 277) with videos related to
Sort By:
Page
of 28
Rheumatology (Oxford, England)
|
December 14, 2007
COBRA combination therapy in daily practice--getting back to the future
M Boers
The Journal of Rheumatology
|
September 16, 2000
MRI for the early detection of sacroiliitis
M Boers
Nederlands Tijdschrift Voor Geneeskunde
|
October 26, 2000
[Roaming through methodology. XXV. Outcome measures, surrogate outcomes, and intermediate measures]
M Boers
The American Journal of Medicine
|
March 1, 1989
The prospects of autopsy: mortui vivos docuerunt? ("Have the dead taught the living?")
M Boers
Arthritis and Rheumatism
|
November 17, 2001
Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy
M Boers,
The Netherlands Journal of Medicine
|
December 17, 2002
EMEA guidelines for trials in osteoporosis: design implications
M Boers
Rheumatic Diseases Clinics of North America
|
June 9, 2001
Rheumatoid arthritis. Treatment of early disease
M Boers
The Journal of Rheumatology
|
October 1, 1994
Predicting outcome of ankylosing spondylitis: prognosis or hindsight?
M Boers
Lancet (London, England)
|
June 22, 2001
NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection
M Boers
The Journal of Rheumatology
|
August 18, 2001
Bias in its coat of many colors
M Boers
Page
of 28